|
gptkbp:instance_of
|
gptkb:isotope
|
|
gptkbp:application
|
radiopharmaceuticals
radiobiology studies
|
|
gptkbp:class
|
alkaline earth metals
|
|
gptkbp:clinical_trial
|
ongoing
bone-targeted alpha therapy
|
|
gptkbp:collaborations
|
international studies ongoing
|
|
gptkbp:color
|
silvery-white
|
|
gptkbp:combatants
|
7.6 Me V
|
|
gptkbp:complications
|
high
|
|
gptkbp:composed_of
|
neutron bombardment
|
|
gptkbp:contraindication
|
severe renal impairment
|
|
gptkbp:discovered_by
|
gptkb:Frederick_Soddy
|
|
gptkbp:displacement
|
5.78 Me V
|
|
gptkbp:dissolved
|
insoluble in water
|
|
gptkbp:duration
|
6 months
|
|
gptkbp:electronegativity
|
[ Rn] 7s²
|
|
gptkbp:emissions_standard
|
alpha particles
|
|
gptkbp:environmental_impact
|
highly radioactive
radioactive waste
|
|
gptkbp:financial_performance
|
gptkb:theorem
|
|
gptkbp:healthcare
|
gptkb:battle
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Radium-223
|
|
gptkbp:invention
|
patented
|
|
gptkbp:is_effective_against
|
effective in pain relief
|
|
gptkbp:is_monitored_by
|
regular blood tests
|
|
gptkbp:isotopes
|
88
alpha-emitting isotope
|
|
gptkbp:lifespan
|
10 days
11.43 days
|
|
gptkbp:manager
|
intravenous
|
|
gptkbp:market
|
available in select markets
|
|
gptkbp:marketed_as
|
gptkb:Bayer_AG
|
|
gptkbp:melting_point
|
1413 ° C
1000 ° C
|
|
gptkbp:mode
|
alpha decay
|
|
gptkbp:parent
|
gptkb:Radon-219
Uranium-235
|
|
gptkbp:population
|
5.5 g/cm³
|
|
gptkbp:power_output
|
5.27 e V
|
|
gptkbp:price
|
high
|
|
gptkbp:produced_by
|
limited
neutron activation of radium-226
|
|
gptkbp:provides_information_on
|
follow established protocols
|
|
gptkbp:receives_funding_from
|
available for studies
|
|
gptkbp:regulatory_compliance
|
controlled substance
|
|
gptkbp:roll_rate
|
3/2
|
|
gptkbp:safety_features
|
gptkb:stock_market_index
requires shielding
|
|
gptkbp:scholarships
|
available through healthcare providers
|
|
gptkbp:side_effect
|
nausea, fatigue
|
|
gptkbp:storage
|
cool, dry place
|
|
gptkbp:student_enrollment
|
specific cancer types
|
|
gptkbp:symbol
|
gptkb:Ra-223
|
|
gptkbp:traded_on
|
gptkb:Xofigo
|
|
gptkbp:transportation
|
regulated material
|
|
gptkbp:uses
|
treatment of metastatic prostate cancer
|
|
gptkbp:water_management
|
specialized disposal required
|
|
gptkbp:year_created
|
1934
|
|
gptkbp:bfsParent
|
gptkb:Radium
|
|
gptkbp:bfsLayer
|
4
|